107 related articles for article (PubMed ID: 31721182)
1. Social connectedness and mortality after prostate cancer diagnosis: A prospective cohort study.
Wu Z; Nguyen NH; Wang D; Lynch BM; Hodge AM; Bassett JK; White VM; Borland R; English DR; Milne RL; Giles GG; Dugué PA
Int J Cancer; 2020 Aug; 147(3):766-776. PubMed ID: 31721182
[TBL] [Abstract][Full Text] [Related]
2. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks.
Thomas AA; Pearce A; Sharp L; Gardiner RA; Chambers S; Aitken J; Molcho M; Baade P
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e31-e40. PubMed ID: 27558311
[TBL] [Abstract][Full Text] [Related]
4. Physical Activity and Survival After Prostate Cancer.
Friedenreich CM; Wang Q; Neilson HK; Kopciuk KA; McGregor SE; Courneya KS
Eur Urol; 2016 Oct; 70(4):576-585. PubMed ID: 26774959
[TBL] [Abstract][Full Text] [Related]
5. Recreational Physical Activity in Relation to Prostate Cancer-specific Mortality Among Men with Nonmetastatic Prostate Cancer.
Wang Y; Jacobs EJ; Gapstur SM; Maliniak ML; Gansler T; McCullough ML; Stevens VL; Patel AV
Eur Urol; 2017 Dec; 72(6):931-939. PubMed ID: 28711382
[TBL] [Abstract][Full Text] [Related]
6. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
[TBL] [Abstract][Full Text] [Related]
7. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer.
Berglund A; Garmo H; Robinson D; Tishelman C; Holmberg L; Bratt O; Adolfsson J; Stattin P; Lambe M
Eur J Cancer; 2012 Jan; 48(1):75-84. PubMed ID: 21852113
[TBL] [Abstract][Full Text] [Related]
8. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
[TBL] [Abstract][Full Text] [Related]
9. Social networks and survival after breast cancer diagnosis.
Beasley JM; Newcomb PA; Trentham-Dietz A; Hampton JM; Ceballos RM; Titus-Ernstoff L; Egan KM; Holmes MD
J Cancer Surviv; 2010 Dec; 4(4):372-80. PubMed ID: 20652435
[TBL] [Abstract][Full Text] [Related]
10. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
Sarkar RR; Parsons JK; Bryant AK; Ryan ST; Kader AK; McKay RR; D'Amico AV; Nguyen PL; Hulley BJ; Einck JP; Mundt AJ; Kane CJ; Murphy JD; Rose BS
JAMA Intern Med; 2019 Jun; 179(6):812-819. PubMed ID: 31058923
[TBL] [Abstract][Full Text] [Related]
11. Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).
Russo AL; Chen MH; Aizer AA; Hattangadi JA; D'Amico AV
BJU Int; 2012 Oct; 110(7):973-9. PubMed ID: 22954029
[TBL] [Abstract][Full Text] [Related]
12. Vasectomy and Prostate Cancer Incidence and Mortality in a Large US Cohort.
Jacobs EJ; Anderson RL; Stevens VL; Newton CC; Gansler T; Gapstur SM
J Clin Oncol; 2016 Nov; 34(32):3880-3885. PubMed ID: 27646949
[TBL] [Abstract][Full Text] [Related]
13. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Dalton SO; Nørgaard M; Pottegård A; Hallas J; Sørensen HT; Friis S
Ann Intern Med; 2019 Apr; 170(7):443-452. PubMed ID: 30831581
[TBL] [Abstract][Full Text] [Related]
14. Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.
Dhillon PK; Kenfield SA; Stampfer MJ; Giovannucci EL; Chan JM
Cancer Prev Res (Phila); 2012 Oct; 5(10):1223-8. PubMed ID: 22961777
[TBL] [Abstract][Full Text] [Related]
15. Physical activity and survival among men diagnosed with prostate cancer.
Bonn SE; Sjölander A; Lagerros YT; Wiklund F; Stattin P; Holmberg E; Grönberg H; Bälter K
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):57-64. PubMed ID: 25527697
[TBL] [Abstract][Full Text] [Related]
16. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR
JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865
[TBL] [Abstract][Full Text] [Related]
17. Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.
Aizer AA; Chen MH; Hattangadi J; D'Amico AV
BJU Int; 2014 Jan; 113(1):43-50. PubMed ID: 23473327
[TBL] [Abstract][Full Text] [Related]
18. The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona.
Murta-Nascimento C; Romero AI; Sala M; Lorente JA; Bellmunt J; Rodero NJ; Lloreta J; Hospital À; Burón A; Castells X; Macià F
Eur J Cancer Prev; 2015 Jul; 24(4):335-9. PubMed ID: 25075878
[TBL] [Abstract][Full Text] [Related]
19. Body mass index and weight change in men with prostate cancer: progression and mortality.
Bonn SE; Wiklund F; Sjölander A; Szulkin R; Stattin P; Holmberg E; Grönberg H; Bälter K
Cancer Causes Control; 2014 Aug; 25(8):933-43. PubMed ID: 24810654
[TBL] [Abstract][Full Text] [Related]
20. Validation of a subclassification for high-risk prostate cancer in a prospective cohort.
Butler SS; Dee EC; Lamba N; Sha ST; Mahal BA; Whitbeck A; Makkar R; Wangoe J; Mouw KW; Nguyen PL; Muralidhar V
Cancer; 2020 May; 126(10):2132-2138. PubMed ID: 32073662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
